Integrated Filing — IndAS



General information about company

Scrip Code 544184
NSE Symbol BOROSCI
MSEI Symbol NOTLISTED
ISIN INE02L001032
Name of company BOROSIL SCIENTIFIC LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 03-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 27-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 03-08-2026   15:10:00
End date and time of board meeting 03-08-2026   16:15:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 9,989.68 9,989.68
Other income 279.62 279.62
Total income 10,269.30 10,269.30
2 Expenses
(a) Cost of materials consumed 3,896.58 3,896.58
(b) Purchases of stock-in-trade 39.17 39.17
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (869.06) (869.06)
(d) Employee benefit expense 1,795.05 1,795.05
(e) Finance costs 10.45 10.45
(f) Depreciation, depletion and amortisation expense 444.91 444.91
(f) Other Expenses
1 Other expenses 4,021.09 4,021.09
Total other expenses 4,021.09 4,021.09
Total expenses 9,338.19 9,338.19
3 Total profit before exceptional items and tax 931.11 931.11
4 Exceptional items 0.00 0.00
5 Total profit before tax 931.11 931.11
6 Tax expense
7 Current tax 175.48 175.48
8 Deferred tax 71.28 71.28
9 Total tax expenses 246.76 246.76
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 684.35 684.35
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 684.35 684.35
17 Other comprehensive income net of taxes (6.29) (6.29)
18 Total Comprehensive Income for the period 678.06 678.06
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 889.47 889.47
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.77 0.77
Diluted earnings (loss) per share from continuing operations 0.77 0.77
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.77 0.77
Diluted earnings (loss) per share from continuing and discontinued operations 0.77 0.77
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes on Unaudited Standalone Financial Results for the quarter ended 30th June, 2026: 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held o�n 3rd August, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the above results. 2. Exceptional items comprise: i) Rs. 661.31 lakhs for the quarter ended 30th June, 2025 and the year ended 31st March, 2026, representing expenditure incurred towards the Voluntary Retirement Scheme (VRS) for eligible workers at the Company's plant located at Village Ambad, Nashik, Maharashtra and ii) Rs. 191.51 lakhs for the year ended 31st March, 2026, representing the one-time incremental impact arising from the implementation of the new Labour Codes. 3. The figures for the corresponding previous period/year have been rearranged/ regrouped, wherever necessary, to make them comparable. The figures for the quarter ended 31st March, 2026 is the balancing figures between the audited figures of the full financial year and the published year to date figures upto the third quarter of the respective financial year. For Borosil Scientific Limited Place: Mumbai Vinayak Patankar Date : 3rd August, 2026 Whole-time Director & CEO (DIN 07534225)



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Scientific – Laboratory Glass & equipment and Process System 5,982.56 5,982.56
2 Glassware 3,836.21 3,836.21
3 Others 0.0017091 0.0017091
Total Segment Revenue 9,989.68 9,989.68
Less: Inter segment revenue 0.00 0.00
Revenue from operations 9,989.68 9,989.68
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Scientific – Laboratory Glass & equipment and Process System 1,253.56 1,253.56
2 Glassware 19.00 19.00
3 Others 42.97 42.97
Total Profit before tax 1,315.53 1,315.53
i. Finance cost 10.45 10.45
ii. Other Unallocable Expenditure net off Unallocable income 373.97 373.97
Profit before tax 931.11 931.11
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Scientific – Laboratory Glass & equipment and Process System 15,349.95 15,349.95
2 Glassware 12,764.58 12,764.58
3 Others 336.64 336.64
Total Segment Asset 28,451.17 28,451.17
Un-allocable Assets 26,999.25 26,999.25
Net Segment Asset 55,450.42 55,450.42
4 Segment Liabilities
Segment Liabilities
1 Scientific – Laboratory Glass & equipment and Process System 4,844.86 4,844.86
2 Glassware 2,281.42 2,281.42
3 Others 82.25 82.25
Total Segment Liabilities 7,208.53 7,208.53
Un-allocable Liabilities 1,350.92 1,350.92
Net Segment Liabilities 8,559.45 8,559.45
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) As per Indian Accounting Standard 108 on ‘Operating Segment’ (Ind-AS 108), the Company has reported Segment information, as described below: Scientific – Laboratory Glass & equipment and Process System:- Comprising of items used in laboratories, production floor and research and development Glassware:- Pharmaceutical primary packaging and domestic glassware items Others :- Comprising of Filter Paper etc. Unallocated:- Consists of income, expenses, assets and liabilities which can not be directly identified to any of the above segments.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/(losses) on defined benefit plans (8.41) (8.41)
Total Amount of items that will not be reclassified to profit and loss (8.41)
2 Income tax relating to items that will not be reclassified to profit or loss (2.12) (2.12)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (6.29) (6.29)